Skip to content

Research paper

Enteral iron supplementation in preterm and low birth weight infants.

The Cochrane database of systematic reviews
Q1
Mar 2012
Citations: 93
Influential: 2
Systematic Reviews / Meta-Analyses
85

Study answer

What this study found

Enteral iron supplementation probably improves hematologic iron status, with slightly higher hemoglobin levels, better iron stores, and a lower risk of iron deficiency anemia than no supplementation. The review found no clear evidence that iron supplementation improves long-term neurodevelopment or growth. Doses greater than about 2 to 3 mg/kg/day did not appear to provide additional hematologic benefit, and earlier initiation may improve hematologic parameters, but the best timing and duration remain uncertain.

Study & population
Systematic review and meta-analysis of 26 trials including 2726 infants.
Intervention
Prophylactic enteral iron supplementation in preterm and low birth weight infants, delivered in a variety of oral/enteral formulations including ferrous sulfate, ferric ammonium citrate, iron polymaltose complex, and iron-fortified formula.
Key limitation
The evidence base was heterogeneous, with many small and older trials using different iron formulations, doses, start times, durations, and feeding contexts.
View sourceOpen PDF

Original abstract

BACKGROUND Preterm infants are at risk of exhausting their body iron stores much earlier than healthy term newborns. It is widespread practice to give enteral iron supplementation to preterm and low birth weight infants to prevent iron deficiency ana…